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THE EFFECTS OF ASPARTAME ON LOCOMOTION
AND BODY WEIGHT IN RATS
Linda Dianne Dykema Larsen, M.A.
Western Michigan University, 1985
Nutrients, when ingested in isolation from other food stuffs or in
excess, may produce drug-like action on neurotransmitter activity in
the CNS.

Administration of aspartame exclusively or in combination

with d-amphetamine was found to produce weight loss and display of
emotionality in rats as measured in an open field apparatus.

The

possible neurochemical action of aspartame was discussed relative to
the well documented stimulatory effects on catecholamines of d-amphet
amine and three putative mechanisms were explored: 1) formation of
minor amines from the increased precursor pool, 2) increased synthesis
of catecholamines in response to the increased precursor pool, and 3)
decrease in CNS levels of the putative neuro-inhibitor serotonin due
to competative uptake at the blood-brain barrier.
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CHAPTER I
INTRODUCTION
In July of 1981 the United States Food and Drug Administration
approved the nutritive sweetener Nutrasweet for use in cold cereals,
drink mixes, sugarless gums, instant coffees, teas, geletins, and
other dry food stuffs.

In July of 1983 this approval was extended to

use in carbonated beverages.

Nutrasweet is J.D. Searle's name for

aspartame which is a compound of dual amino acid composition: phenyl
alanine and aspariate.

Soon after Nutrasweet use became wide spread,

reports of undesirable side effects began to surface.

Carbohydrate

craving and irritability were amoung the most frequent and severe of
these effects.

This study was an attempt to assess the impact of the

compound aspartame on the body weight and locomotor activity of rats.
In this study dietary intake was held constant in order to assess
the impact of aspartame on body weight exclusive of fluctuations in
carbohydrate intake.

Carbohydrate concentrations in the blood and

cerebral spinal fluids may effect the concentration of amino acid
precursors in the brain thus altering neurotransmitter levels and the
corresponding behaviors such as feeding mechanisms.
The second behavior to be assessed in this study is that of loco
motion or exploratory behavior.

Typically, when rats are exposed to

an open field apparatus they display normal exploratory behavior.
Freezing or absence of locomotion accompanied by urination or defeca
tion is sometimes referred to as stereotypy or emotionality (Archer,
1
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1973).
The concept of linking locomotor or exploratory behavior to
emotionality in rats is not new (Archer, 1973).

Research, however,

associating emotionality with levels or activity of brain catechol
amines is relativily recent (Morgan, 1982, Olson and Morgan, 1982).
Test subjects subjectivily scored as exhibiting emotional behavior
were found upon histological examination to have consistantly elevated
levels of norepinephine when compared to controls.

A number of mech

anisms through which aspartame may effect brain levels of neurotrans
mitters may be proposed.

Central to all of these is the rise in tyro

sine and phenylalanine relative to other precursors in the central
nervous system (CNS).

Secondary to the elevation of precursors is the

change in neurotransmitter concentration which ensures.
It may be postulated that alteration of brain concentrations or
balance of neurotransmitters may produce measurable changes in behav
Chemical agents which are known to produce pharmacological

ior.

effects in the central nervous system and on corresponding behaviors
may therefore be of aid in determining the effects of dietary·sub
stances.

D-amphetamine was employed in this study in order to elicit

increased catecholamine activity in the test subjects.

Amphetamine

induced increased in release of newly synthesized catecholamines pro
duce corresponding increases in locomotor activity (Seiden and Dykstra,
1977).

In addition the affect of amphetamines on amine concentrations

has long been employed to stimulate wieght loss.
In this study an attempt was made to compare the behavioral
effects of d-amphetamine to aspartame ingestion and to assess the

3
possible effects of the interaction between the two.

Two dependent

varibles were employed; tabulated score of locomotor or exploratory
behavior, and the total amount of body weight lost or gained over the
ten day dosing period.

The addition of the housing variable was an

attempt to assess the impact of stress on aspartame ingestion.

CHAPTER II
MATERIALS AND METHODS

Subjects
Thrity-two male eperimentally naive Sprague-Dawley rats served as
subjects.

Body weights ranged from

220

to 320 grams prior to initia

tion of the study.
Apparatus
Housing consisted of a standard metal cage measuring
30.S cm (696.8 cm 2).

22.9

cm by

Subjects assigned to the aggregate experimental

condition were housed in groups of four.

The remainder of subjects

were housed singly.

The open field apparatus consisted of a 114.3 cm by 114.3 cm
(13064.49 cm 2 ) plywood box.

A grid divided into thrity-six equal

(19.1 cm by 19.1 cm) squares was imposed on the black interior.
The original sides of the box measured 15.0 cm in height, how
ever, in practice the height was raised to at least 91.S cm on all
sides.
Procedures
Thrity-two rats were assigned, through the use of a random number
table, to eight experimental groups.

Each group was exposed to a

single or group housing condition and d-amphetamine and/or aspartame
4

5
were

administered

four

anim als

orally by feeding.

were housed in

a

cage.

In the group housed condition
The experiment al conditions

are

listed in T able 1 for e ach group.
T able 1
Description of experiment al conditions including group number, dosage
amounts of asp artame and d-amphetamine in milligrams per kilogram of
body weight, and housing condition.

HOUSINGa

ASPARTAME
mg/kg

d-AMPHETAMINE
mg/kg

o.o
o.o

Single

2.0

Single

IV

o.o
o.o
o.o
o.o

2.0

Aggreg ate

V

100.0

VI

TREATMENT
GROUP
I
II
III

Aggregate

Single

100.0

o.o
o.o

VII

100.0

2.0

Single

VIII

100.0

2.0

Aggreg ate

a

Four r ats were housed together under the
Animals were

allowed

aggregr ate

Aggreg ate

condition.

free access to w ater and the daily

of 20 grams of Purin a L abor atory Chow per subject.

allow ance

A twelve hour

light-d ark cycle w as m aintained throughout the study.
Subjects were maint ained on
r at chow per subject per d ay.
resulting powder w as

a

controlled diet of twenty grams of

The pellets were pulverized

adulter ated

with the

appropri ate

and

the

dos age of Equal
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sugar substitute and/or d-amphetamine.

Each of the subjects received

the dosage amounts listed in Table 1 for ten consecutive days.
The rat chow was presented to the rats in metal feeders 8 cm in
diameter and 6.5 cm in height which were fitted with metal lids.

A

circular hole in the lid allowed access to the food.
Subjects were weighed and the baseline data of the open field
measure were gathered on day 1 of the study prior to the first drug
administration.

Weights were again taken and post dosage data was

gathered on day ten of the study.
Exposure to the open field apparatus consisted of a five minute
period during which the rat was allowed to explore freely.

Each

subject was placed in the corner square of the grid designated as
square #15 at the initiation of the trial.

Testing took place in a

quite, but not sound deadened room and the apparatus was cleansed of
urine and fecal material between trials.

Performance on the locomotor

variable was tabulated as follows;
2 points

central square traversed - 1 square

2

other square traversed - 1 square

1 point

2

fecal material present - bolus • -2 points
urination present • -1 point
A measure of "emotionality" of rats can be derived from the loco
motor behavior or exploratory behavior shown by the animals as well as
from an index of autonomic activity based upon a count of fecal boli
and urine output.

Typically animals who are described as presenting

"fear" or "anxiety" will freeze (remain immobile) and defecate and/or
urinate.

In the instance described here we measure the animal's

7

locomotor activity as well as counting the number of fecal boli and the
presence of urine.

These scores were combined to yield a measure of

emotionality so that the data could be compared with other studies in
this area which have used a combination score (Olson and Morgan, 1982).

CHAPTER III
RESULTS
Locomotor Scores
'The locomotor score is the sum of the points awarded for movement
within the area of the open apparatus. These data are presented in
Figure 1 as a function of conditions.

'Three way analysis of variance

of the locomotor scores revealed a significant omnibus F � 28.823,
p, .001.
The main effect of aspartame on locomotion was significant
(p ( .001).

Aspartame groups (V through VIII) were found to score much

lower on the locomotor variable than either the controls (I and II) or
the amphetamine groups (III and IV).
'The main effect of d-amphetamine on locomotion was also signifi
cant (p ( .001).

'This effect was a result of the much higher locomotor

scores of groups III and IV which received d-amphetamine but no aspartame.
The effect of the housing variable was not significant (p • .494),
nor was the interaction of d-amphetamine, aspartame and housing
(p a .465).
The interaction of d-amphetamine and aspartame was significant
(p ( .001).

'The simple main effects of the interaction are presented

in the first four comparisons of Table 2.

Groups which received

aspartame were found to score lower on the locomotor variable with or
8
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Table 2
Locomotor Scores (Simple Main Effects)

Comparison of ASP/No ASP Groups
27.98*

No AMP (I & II vs. V & VI)

144.90*

AMP (III & IV vs. VII & VIII)
Comparison of AMP/No AMP Groups
No ASP (I & II vs. III & IV)

46.45*

ASP (V & VI vs. VII & VIII)

0.01

Comparison of AMP/No AMP Groups
Single (I & II vs. III & VII)

27.27*

Crowded (II & VI vs. IV & VIII)

25.53*

Comparison of Single/Crowded Groups
No AMP (I & V vs. II & VI)

5.16

AMP (III & VII vs. IV & VIII)

4.42

* Bonferroni F Critical Value

a

7.29, p • .05.

Note. Starred values indicate Bonferroni statistics greater
than the critical value.
without the administration of d-amphetamine.

Differences between groups

which received amphetamines (III and IV) and those which did not (I and
II) were found only in the absence of aspartame.

No difference was

found to exist in locomotor scores of groups which received amphetamines
(VII and VIII) and those which did not (V and VI) in the presence of
aspartame.

11
The interaction of aspartame and housing was not found to be sig
nificant (p = .653).
The interaction of amphetamine administration and housing was
significant (p ( .032).

The simple main effects of this interaction

are presented in the fifth through eighth comparisons of Table 2.
Groups which received amphetamines were found to score higher on the
locomotor variable under both single and crowded conditions.

This

effect was probably a result of the higher locomotor scores exhibited
by groups III and IV.

As expected by the lack of main effect by

housing, single and crowded groups were not found to differ on the
locomotor variable either with or without d-amphetamine.
Weight Gain Scores
The weight gain score was determined as the amount of body weight
in grams gained or lost from day one to day ten of the dosing period.
These data are presented in Figure 2. as the mean weight loss or gain
per group as a function of conditions.

Three way analysis of the

weight gain scores revealed a significant omnibus F a 19.901, p ( .001.
These data show a weight loss under all conditions with the expception
of the single housed controls (group I).

Each of the main effects of

aspartame, amphetamine and housing were also significant (p ( .001).
The overall interaction of the three variables, however, was not sig
nificant (p � .084).
The interaction of aspartame and amphetamine was again found to
be significant (p ( .001).

The simple main effects of this interaction

are presented in the first four comparisons of Table 3.

Groups which
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Table 3
Weight Gain Scores (Simple Main Effects)
Comparison of ASP/No ASP Groups
54.SO*

No AMP (I & II vs. V & VI)

s.84

AMP (III & IV vs. VII & VIII)
Comparison of AMP/No AMP Groups
No ASP (I & II vs. III & IV)

88.29*

ASP (V & VI vs. VII & VIII)

0.16

Comparison of AMP/No AMP Groups
48.72*

Single (I & II vs. III & VII)

9.53*

Crowded (II & VI vs. IV & VIII)
Comparison of Single/Crowded Groups

24.67*

No AMP (I & V vs. II & VII)
AMP (III & VII vs. IV & VIII)

1.1s

* Bonferroni F Critical Value � 7.29, p = .OS.
Note. Starred values indicate Bonferroni statistics greater
than the critical value.
received only aspartame (V and VI) lost more weight than controls
(I and II).

Also groups which received only amphetamine (III and IV)

lost more weight than controls (I and II).

No difference was found to

exist in the amount of weight lost by these groups (III and IV, V and
VI) and the amount lost by groups which received both aspartame and
amphetamine (VII and VIII).
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The interaction of housing and aspartame was not siginificant
(p = 0.084).
The interaction

of amphetamines and housing was found to be

significant (p < .011).

The simple main effects of this interaction

are presented in the fifth through eighth comparisons of Table 3.
Groups which received amlphetamines lost more weight than those which
did not under both single and crowded housing conditions.

Groups

housed in crowded conditions lost more body weight than those in
single housing when no amphetamines were administered.

This is a

result of the inclusion of group I, which gained weight, in the com
parison.

CHAPTER IV
DISCUSSION
Rats maintained on an aspartame adulterated diet exhibited less
locomotion and lost more body weight than controls.

Amphetamine

administration in addition to aspartame did not significantly alter
the locomotor activity and weight loss for either condition of housing
(VII and VIII).

Comparison of groups (VII and VIII) which received

aspartame with amphetamine and those which received amphetamine alone
(III and IV) showed less locomotor activity on the part of the former.
No difference was found to exist, however, between groups which
received aspartame with amphetamine (VII and VIII) and those which
received aspartame alone (V and VI).
The behavior exhibited in the open field apparatus by the controls
may be considered normal exploration.

The amphetamine groups (III and

IV) tended to move more frequently and more rapidly than controls.
The aspartame groups (V through VIII) moved less frequently than both
the controls and the amphetamine groups.

Urination and defecation

occured infrequently for all groups.
In this study single housed control group I gained body weight.
All other groups lost weight.
The stress factor of housing did not produce a significant inter
action with aspartame for either dependent variable.

The significant

main effect of housing on weight loss did not appear to be a result of
competition for food.
15
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Three major monoamines are norepinephrine (NE), dopamine (DA),
and serotonin (S-HT).

Compounds which alter the metabolic balance of

these substances in the central nervous system (CNS) may produce corre
sponding changes in behavior.
known CNS stimulant.

One such substance is d-amphetamine, a

Amphetamines induce increases in locomotor activ

ity in a dose-dependent manner.

At dosage of 2.0 to S.O mg/kg of body

weight locomotor activity is increased (Seiden and Dykstra, 1977).
Such behavior has been shown to be accompanied by an increase in syn
thesis and turn over rate of NE and DA in the CNS (Olson and Morgan,
1982).

At higher dosages, )5.0 mg/kg, amphetamines-induce behaviors

defined as stereotypical such as freezing or absence of forward loco
motion accompanied by urination or defecation.

These behaviors are

also associated with heightened neurotransmitter activity in the CNS.
The emotional or stereotypical behavior of aspartame fed rats as
illustrated by significantly lowered locomotor scores suggests that
aspartame may produce an alteration of neurotransmitter balance or
activity in the CNS.
There are a number of possible mechanisms through which aspar
tame may alter the neurotransmitter balance of the CNS.

Primary to

the consideration of any of these is the role of precursor in the rate
of metabolic synthesis.

Amino acid precursors of monoamines are

transported across the blood-brain barrier by the competitive amino
acid transport carrier system.

The capillaries of the brain are

unlike those in other areas of the body in that they are unfenestrat
ed, therefore inhibiting diffusion of compounds from circulatory
fluids.

Movement of metabolic substrates between the blood and the
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brain is of necessity an active and selective process probably perform
ed by transport systems located in the cerebral endothelial cell.
Movement of metabolic substrates via the transport system is
dependent not only on the amount of amino acid in circulation but also
on the relative levels of other amino acids.

A single carrier mole

cule transports six large amino acids across the blood-brain barrier:
tyrosine, phenylalanine, leucine, isoleucine, valine, and tryptophan.
The amino acids compete with one another for attachment and transport
by the carrier system (Wurtman, 1982).

Ingestion of compounds which

contain high levels of a particular amino acid, such as phenylalanine
in the case of aspartame, produce corresponding increase in the brain's
uptake of that amino acid and a proportional increase in neurotransmit
ter systhesis (Fernstrom, 1983, Weisburd, 1984).
Tyrosine is the amino acid precursor to the catecholamines, how
ever, phenylalanine is converted to tyrosine in both brain and liver
tissues.

Following ingestion of large amounts of protein or amino

acids, transport of tyrosine and phenylalanine
facilitated.
occurs.

into the brain is

Initially a rise in the rate of synthesis of NE and DA

'nle rate limiting step in the synthesis of catecholamines is

catalyzed by tyrosine hydroxylase.

Research suggests that an inter

play exists between substrate control and receptor mediated feedback
inhibition of tyrosine hydroxylase activity.

A rise in brain levels

of NE and DA results in feedback inhibition on enzymatic activity thus
limiting further catecholamine synthesis (Pardridge, 1977).
Tyrosine hydroxylase may also have an affinity for phenylalanine
and in fact the rate of phenylalanine hydroxylation by tyrosine

18

hydroxylase in the brain may be as high as that of tyrosine.

In

addition, increased concentrations of phenylalanine may act to inhibit
tyrosine hydroxylase (Pardridge, 1977).

It is unlikely, therefore,

that aspartame, by elevating serum and brain levels of phenylalanine,
produces an actual increase of NE and DA in the CNS.
Tyrosine and phenylalanine may also be metabolized in the CNS
through decarboxylation to form the minor amines phenethylamine and
tyramine.

These minor amines could act as false neurotransmitters
Aspartame, by elev

producing corresponding alteration in behavior.

ating the level of phenylalanine in the brain, may therefore produce
an effect analogous to that of d-amphetamine.

As previously stated

the low dose of 2 mg/kg of body weight administered to rats in this
study produced an increase in locomotor activity.

The absence of

forward locomotion observed in the aspartame fed rats may be similar
to the stereotyped behavior at high doses of amphetamines (Seiden and
Dykstra, 1977).

The weight loss observed in aspartame fed rats may be

due to an alteration in the balance of neurotransmitters (NE and DA to
5-HT) or as a direct result of the production of false neurotrans
mitters.
Another consequence of increasing the amino acid precursor pool
may be abnormal transmethylation.

This reaction may result in the

production of hallucinogenic derivatives.

Exogenous hallucinogens

such as LSD have been found to inhibit neural activity in serotonergic
cells of the raphe-nuclei in the midbrain.

Raphe cells are primarily

occupied in regulation of sleep and basic emotion, both of which may
be affected by ingestion of large amounts of aspartame (Thompson,
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1975).

Disruption of the function of the raphe cells may produce the

emotional behavior observed in aspartame fed rats.
A more probable explaination for the effects of aspartame on
behavior is direct suppression of 5-HT.

As stated earlier, tryptophan

competes for transport into the brain via the amino acid transport
system,
tion.

Tryptophan is the amino acid substrate for serotonin produc
When serum levels of the other neutral amino acids are elev

ated, uptake of tryptophan into the brain is blocked.

Injection of

phenylalanine into adult rats has been found to produce a corresponding
depression of brain tryptophan levels.

Even larger reduction of brain

tryptophan may be produced by a diet containing excess amounts of
phenylalanine (Ferstrom, 1983).

Serotonin production is substrate

limited unlike NE and DA which are enzymatically limited.

When the

ratio of tryptophan to other amino acids in the blood is altered there
is a corresponding alteration of 5-HT synthesis in the CNS (Pardridge,
1977).
Tryptophan is unique amoung the neutral amino acids in that it is
bound to the plasma protein albumin.
immune to the effects of insulin.

Thus bound it is essentially

When a compound such as aspartame

is eaten less tryptophan reaches the brain since there is less of it
in protein than the other amino acids:
cine, isoleucine, or valine.

tyrosine, phenylalanine, leu

In addition, since the ratio of trypto

phan to other amino acids is so low the competition at the blood-brain
barrier is greater.

A carbohydrate rich meal has the opposite effect

because the resulting insulin secretion facilitates the uptake of
amino acids across the cell membranes in tissues other than the CNS.
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The relative plasma level of the albumin bound tryptophan rises
allowing more tryptophan to reach the brain.
These mechanisms may be the basis for neuroregulation of protein
intake.

When rats are allowed free choice of protein diet, total pro

tein consumed was found to be closely correlated with the ratio of
serum tryptophan to the sum of all other competing neutral amino acids
(Ashley and Anderson, 1975).

The clinical observation of excessive

carbohydrate intake by human users of aspartame may also be a result of
these mechanisms.

The carbohydrate· "craving" may be a result of the

tryptophan starved brains effort to minimize competetion at the
blood-brain barrier thus allowing more tryptophan to reach the brain.
The weight loss observed in this study may be an affect of elevated
dietary intake of phenylalanine and the resulting lowered tryptophan
and serotonin levels in the CNS.
Decreases of 5-HT levels in the CNS have been associated with a
varie'.ty of behaviors including sensitivity to heat and shock,
increased wakefullness, increased aggressive behavior, and increased
susceptibility to seizures.

Evidence from clinical reports suggests

that the users of aspartame may experience insomnia and irritability
or difficulty with interpersonal relationships which may be a result
of lowered 5-HT synthesis in areas of the CNS such as the raphe-nuclei.
Further investigation of aspartame by histochemical methods may be of
use to determine the effect in circumscribed areas of the brain.
Neurotoxicity of a compound may be described as structral or
functional.

The possibility of depression of 5-HT levels is a func

tional consideration.

Aspartame may also produce structral

21

abnormalities in the CNS which are irreversible.

This issue is of

particular importance in view of the wide spread use of aspartame in
products aimed at children. The margin of safety for aspartame of 40
mg/kg body weight per day set by the FDA is based upon data collected
from mature subjects.

This safety margin may be mathematically off a

hundred fold for children (Hunter, 1983).

In rats, the level of amino

acids in the neonatal brain is much higher than in the adult brain.
Restriction of movement of intracellular markers does not assume adult
levels until approximately three weeks of age suggesting that the
blood-brain bar- rier is immature at birth thus allowing greater influx
of blood con- stituents (Pardridge, 1977).

Newborn rats are, however,

much less developed when compared to human infants.

The period of

susceptibility to an increased level of a single amino acid may occur
prenatally rather than postnatally in humans.
The increased levels of phenylalanine and aspartate in the
immature CNS may lead to irreversable brain damage in children.
Aspartate has been implicated, along with glutamate, in the production
of lesions in the arcuate nucleus of the hypothalamus when administered
to neonatal rats (Hunter, 1983).

Lesions of the arcuate nucleus pro

duce a distinct syndrome characterized by obseity, shortness of stature,
and genital abnormalities.

These symptoms are thought to be a disrup

tion of the normal patterns of release of hormones from the hypothalmus.
The critical age and dosage amount required to produce arcuate lesions
in humans has not been established, however, until firm data exists
such compounds should not be approved for wide spread use in products
likely to be consumed in large amounts by children.
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The risk of brain damage presented by phenylalanine has been well
established by research concerning phenylketonuria (PKU).

Products

containing aspartame are required by law to provide a warning statement
on the package.

PKU is a genetic condition in which phenylalanine is

not metabolized and serum levels are elevated.

The excessive phenyl

alanine in the brain produces a depression of neurotransmitter levels
resulting in lack of formation of neural connections.

PKU is a homo

zygous condition, however, the risk of high intake of phenylalanine
for persons heterozygous for PKU has not been established.

The mech

anism through which excessive phenylalanine acts to produce the pro
found retardation observed in PKU subjects has been found to be alter
ation of amino acid transport into the brain resulting in lowered 5-HT
synthesis.

Phenylalanine may also act in high concentrations to inhi

bit tryptophan hydroxylase, the enzyme which is ultilized in production
of 5-HT (Fernstram, 1974).
Further research into the possible effects of aspartame ingestion
should use advanced histological and histochemical techniques.

In

addition, inquires should be made into the safety of the breakdown
products of aspartame such as diketopiperazine.

The FDA decision seems

to have been made on the basis of information provided by the manufac
turer.

These data were reviewed by the World Health Organization in

1980 and 1981.

Unfortunately, no studies involving neonatal animals or

prolonged life span periods were included.

The FDA approval seems to

have been made hastily in response to industry pressure and in the face
of conflicting reports of safety.
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